Lidds AB Financials
LIDDS Stock | SEK 0.11 0.01 8.33% |
Lidds |
Understanding current and past Lidds AB Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Lidds AB's financial statements are interrelated, with each one affecting the others. For example, an increase in Lidds AB's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Lidds AB's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Lidds AB. Check Lidds AB's Beneish M Score to see the likelihood of Lidds AB's management manipulating its earnings.
Lidds AB Stock Summary
Lidds AB competes with Mendus AB, Cantargia, BioInvent International, and Isofol Medical. LIDDS AB develops and sells pharmaceutical products for cancer and other diseases worldwide. It is developing various drugs, such as NZ-2HOF to treat prostate cancer NZ-DTX for lung cancer and solid tumors NZ-DOX for solid tumors NZ-IO, an antibody-based immunotherapy NZ-STING for immuno-oncology and NZ-BELINA for breast cancer. LIDDS AB operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange.Instrument | Sweden Stock View All |
Exchange | Stockholm Exchange |
ISIN | SE0001958612 |
Business Address | Virdings all 32b, |
Sector | Biotechnology |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.liddspharma.com |
Phone | 46 00 44 55 66 |
Currency | SEK - Swedish Kronor |
You should never invest in Lidds AB without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Lidds Stock, because this is throwing your money away. Analyzing the key information contained in Lidds AB's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Lidds AB Key Financial Ratios
There are many critical financial ratios that Lidds AB's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Lidds AB reports annually and quarterly.Return On Equity | -0.89 | |||
Return On Asset | -0.46 | |||
Target Price | 33.0 | |||
Beta | 0.38 |
Lidds Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Lidds AB's current stock value. Our valuation model uses many indicators to compare Lidds AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Lidds AB competition to find correlations between indicators driving Lidds AB's intrinsic value. More Info.Lidds AB is rated second overall in return on equity category among its peers. It also is rated second overall in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Lidds AB's earnings, one of the primary drivers of an investment's value.Lidds AB Systematic Risk
Lidds AB's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Lidds AB volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Lidds AB correlated with the market. If Beta is less than 0 Lidds AB generally moves in the opposite direction as compared to the market. If Lidds AB Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Lidds AB is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Lidds AB is generally in the same direction as the market. If Beta > 1 Lidds AB moves generally in the same direction as, but more than the movement of the benchmark.
Lidds AB November 26, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Lidds AB help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Lidds AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of Lidds AB based on widely used predictive technical indicators. In general, we focus on analyzing Lidds Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Lidds AB's daily price indicators and compare them against related drivers.
Downside Deviation | 14.58 | |||
Information Ratio | 0.0253 | |||
Maximum Drawdown | 64.77 | |||
Value At Risk | (16.67) | |||
Potential Upside | 20.0 |
Additional Tools for Lidds Stock Analysis
When running Lidds AB's price analysis, check to measure Lidds AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lidds AB is operating at the current time. Most of Lidds AB's value examination focuses on studying past and present price action to predict the probability of Lidds AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lidds AB's price. Additionally, you may evaluate how the addition of Lidds AB to your portfolios can decrease your overall portfolio volatility.